{"pmid":32453497,"title":"A new diagnostic strategy for gestational diabetes during the COVID-19 pandemic for the Japanese population.","text":["A new diagnostic strategy for gestational diabetes during the COVID-19 pandemic for the Japanese population.","Diabetes Metab Res Rev","Kasuga, Yoshifumi","Saisho, Yoshifumi","Ikenoue, Satoru","Ochiai, Daigo","Tanaka, Mamoru","32453497"],"journal":"Diabetes Metab Res Rev","authors":["Kasuga, Yoshifumi","Saisho, Yoshifumi","Ikenoue, Satoru","Ochiai, Daigo","Tanaka, Mamoru"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453497","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/dmrr.3351","keywords":["covid-19","diagnosis","gestational diabetes","japanese"],"locations":["Japanese"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Prevention"],"weight":1,"_version_":1667881798521061378,"score":9.490897,"similar":[{"pmid":32033064,"pmcid":"PMC7074297","title":"The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights.","text":["The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights.","From 29 to 31 January 2020, a total of 565 Japanese citizens were evacuated from Wuhan, China on three chartered flights. All passengers were screened upon arrival in Japan for symptoms consistent with novel coronavirus (2019-nCoV) infection and tested for presence of the virus. Assuming that the mean detection window of the virus can be informed by the mean serial interval (estimated at 7.5 days), the ascertainment rate of infection was estimated at 9.2% (95% confidence interval: 5.0, 20.0). This indicates that the incidence of infection in Wuhan can be estimated at 20,767 infected individuals, including those with asymptomatic and mildly symptomatic infections. The infection fatality risk (IFR)-the actual risk of death among all infected individuals-is therefore 0.3% to 0.6%, which may be comparable to Asian influenza pandemic of 1957-1958.","J Clin Med","Nishiura, Hiroshi","Kobayashi, Tetsuro","Yang, Yichi","Hayashi, Katsuma","Miyama, Takeshi","Kinoshita, Ryo","Linton, Natalie M","Jung, Sung-Mok","Yuan, Baoyin","Suzuki, Ayako","Akhmetzhanov, Andrei R","32033064"],"abstract":["From 29 to 31 January 2020, a total of 565 Japanese citizens were evacuated from Wuhan, China on three chartered flights. All passengers were screened upon arrival in Japan for symptoms consistent with novel coronavirus (2019-nCoV) infection and tested for presence of the virus. Assuming that the mean detection window of the virus can be informed by the mean serial interval (estimated at 7.5 days), the ascertainment rate of infection was estimated at 9.2% (95% confidence interval: 5.0, 20.0). This indicates that the incidence of infection in Wuhan can be estimated at 20,767 infected individuals, including those with asymptomatic and mildly symptomatic infections. The infection fatality risk (IFR)-the actual risk of death among all infected individuals-is therefore 0.3% to 0.6%, which may be comparable to Asian influenza pandemic of 1957-1958."],"journal":"J Clin Med","authors":["Nishiura, Hiroshi","Kobayashi, Tetsuro","Yang, Yichi","Hayashi, Katsuma","Miyama, Takeshi","Kinoshita, Ryo","Linton, Natalie M","Jung, Sung-Mok","Yuan, Baoyin","Suzuki, Ayako","Akhmetzhanov, Andrei R"],"date":"2020-02-09T11:00:00Z","year":2020,"_id":"32033064","source":"PubMed","week":"20206|Feb 03 - Feb 09","doi":"10.3390/jcm9020419","keywords":["ascertainment","diagnosis","epidemiology","importation","statistical inference","travel"],"locations":["Japanese","Wuhan","China","Japan","Wuhan"],"countries":["China","Japan"],"countries_codes":["CHN|China","JPN|Japan"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138493027352576,"score":58.08557},{"pmid":32396397,"title":"Managing Diabetes in Pregnancy before, during and after COVID-19.","text":["Managing Diabetes in Pregnancy before, during and after COVID-19.","BACKGROUND: Pregnant women with diabetes are identified as being more vulnerable to the severe effects of COVID-19 and advised to stringently follow social distancing measures. Here we review the management of diabetes in pregnancy before and during the lockdown. METHODS: The majority of antenatal diabetes and obstetric visits are provided remotely, with pregnant women attending hospital clinics only for essential ultrasound scans and labour and delivery. On-line resources for supporting women planning pregnancy as well as for self-management of pregnant women with type 1 diabetes (T1D) using intermittent or continuous glucose monitoring (CGM) are provided. Retinal screening procedures, intrapartum care and the varying impact of lockdown on maternal glycaemic control are considered. Alternative screening procedures have for diagnosing hyperglycaemia during pregnancy and Gestational Diabetes (GDM) are discussed. Case histories describe the remote initiation of insulin pump therapy and automated insulin delivery in T1D pregnancy. RESULTS: Initial feedback suggests that video consultations are well received and that the patient experiences for women requiring face-to-face visits are greatly improved. As the pandemic eases, formal evaluation of remote models of diabetes education and technology implementation, including women's views, will be important. CONCLUSIONS: Research and audit activities will resume and we will find new ways for supporting pregnant women with diabetes to choose their preferred glucose monitoring and insulin delivery.","Diabetes Technol Ther","Murphy, Helen","32396397"],"abstract":["BACKGROUND: Pregnant women with diabetes are identified as being more vulnerable to the severe effects of COVID-19 and advised to stringently follow social distancing measures. Here we review the management of diabetes in pregnancy before and during the lockdown. METHODS: The majority of antenatal diabetes and obstetric visits are provided remotely, with pregnant women attending hospital clinics only for essential ultrasound scans and labour and delivery. On-line resources for supporting women planning pregnancy as well as for self-management of pregnant women with type 1 diabetes (T1D) using intermittent or continuous glucose monitoring (CGM) are provided. Retinal screening procedures, intrapartum care and the varying impact of lockdown on maternal glycaemic control are considered. Alternative screening procedures have for diagnosing hyperglycaemia during pregnancy and Gestational Diabetes (GDM) are discussed. Case histories describe the remote initiation of insulin pump therapy and automated insulin delivery in T1D pregnancy. RESULTS: Initial feedback suggests that video consultations are well received and that the patient experiences for women requiring face-to-face visits are greatly improved. As the pandemic eases, formal evaluation of remote models of diabetes education and technology implementation, including women's views, will be important. CONCLUSIONS: Research and audit activities will resume and we will find new ways for supporting pregnant women with diabetes to choose their preferred glucose monitoring and insulin delivery."],"journal":"Diabetes Technol Ther","authors":["Murphy, Helen"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396397","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1089/dia.2020.0223","topics":["Prevention"],"weight":1,"_version_":1666627828074938368,"score":41.678856},{"pmid":32452050,"title":"The outlook for diagnostic purposes of the 2019-novel coronavirus disease.","text":["The outlook for diagnostic purposes of the 2019-novel coronavirus disease.","At the end of December 2019, a novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) appeared as the third unheard of outbreak of human coronavirus infection in the 21st century. First, in Wuhan, China, the novel SARS-CoV2 was named by the World Health Organization (WHO), as 2019-nCOV (COVID-19), and spread extremely all over the world. SARS-CoV2 is transmitted to individuals by human-to-human transmission leading to severe viral pneumonia and respiratory system injury. SARS-CoV2 elicits infections from the common cold to severe conditions accompanied by lung injury, acute respiratory distress syndrome, and other organ destruction. There is a possibility of virus transmission from asymptomatic cases as active carriers, in addition to symptomatic ones, which is a crucial crisis of COVID-19 that should be considered. Hence, paying more attention to the accurate and immediate diagnosis of suspected and infected cases can be a great help in preventing the rapid spread of the virus, improving the disease prognosis, and controlling the pandemic. In this review, we provide a comprehensive and up-to-date overview of the different types of Clinical and Para-clinical diagnostic methods and their practical features, which can help understand better the applications and capacities of various diagnostic approaches for COVID-19 infected cases.","J Cell Physiol","Tahmasebi, Safa","Khosh, Elnaz","Esmaeilzadeh, Abdolreza","32452050"],"abstract":["At the end of December 2019, a novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) appeared as the third unheard of outbreak of human coronavirus infection in the 21st century. First, in Wuhan, China, the novel SARS-CoV2 was named by the World Health Organization (WHO), as 2019-nCOV (COVID-19), and spread extremely all over the world. SARS-CoV2 is transmitted to individuals by human-to-human transmission leading to severe viral pneumonia and respiratory system injury. SARS-CoV2 elicits infections from the common cold to severe conditions accompanied by lung injury, acute respiratory distress syndrome, and other organ destruction. There is a possibility of virus transmission from asymptomatic cases as active carriers, in addition to symptomatic ones, which is a crucial crisis of COVID-19 that should be considered. Hence, paying more attention to the accurate and immediate diagnosis of suspected and infected cases can be a great help in preventing the rapid spread of the virus, improving the disease prognosis, and controlling the pandemic. In this review, we provide a comprehensive and up-to-date overview of the different types of Clinical and Para-clinical diagnostic methods and their practical features, which can help understand better the applications and capacities of various diagnostic approaches for COVID-19 infected cases."],"journal":"J Cell Physiol","authors":["Tahmasebi, Safa","Khosh, Elnaz","Esmaeilzadeh, Abdolreza"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452050","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jcp.29804","keywords":["covid-19","diagnosis","molecular assays","radiological findings","serological assays"],"locations":["Wuhan","China","Clinical","Para"],"countries":["China","Brazil"],"countries_codes":["CHN|China","BRA|Brazil"],"topics":["Diagnosis"],"weight":1,"_version_":1667983494485114880,"score":40.311623}]}